Skip to main content
padlock icon - secure page this page is secure
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 2, 2009

Articles

Targeted Tumor Therapies at a Glance
pp. 89-93(5)
Authors: Fuchs, H.; Bachran, C.

Favourites:
ADD

Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family
pp. 94-103(10)
Authors: Bremer, E.; de Bruyn, M.; Wajant, H.; Helfrich, W.

Favourites:
ADD

Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma
pp. 104-109(6)
Authors: Frankel, A. E.; Zuckero, S. L.; Mankin, A. A.; Grable, M.; Mitchell, K.; Lee, Y. J.; Neville, D. M.; Woo, J. H.

Favourites:
ADD

Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
pp. 110-117(8)
Authors: Hirsch, B.; Brauer, J.; Fischdick, M.; Loddenkemper, C.; Bulfone-Paus, S.; Stein, H.; Durkop, H.

Favourites:
ADD

Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen
pp. 118-125(8)
Authors: Elsasser-Beile, U.; Buhler, P.; Wolf, P.

Favourites:
ADD

Convection-Enhanced Delivery: Neurosurgical Issues
pp. 126-130(5)
Author: Hall, W. A.

Favourites:
ADD

Reducing the Immunogenicity of Protein Therapeutics
pp. 131-139(9)
Author: Onda, Masanori

Favourites:
ADD

Saponins as Tool for Improved Targeted Tumor Therapies
pp. 140-151(12)
Authors: Fuchs, H.; Bachran, D.; Panjideh, H.; Schellmann, N.; Weng, A.; Melzig, M. F.; Sutherland, M.; Bachran, C.

Favourites:
ADD

Targeting: The ADEPT Story So Far
pp. 152-157(6)
Author: Bagshawe, K. D.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more